References
- Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med 2015;188:167–179
- Ates I, Ozkayar N, Inan B, et al. Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension. J Am Soc Hypertens 2016;10:159–166
- Yazici O, Dogan M, Erel O, et al. The importance of thiol/disulphide homeostasis in patients with advanced colorectal cancer receiving modified fluorouracil and leucoverin plus oxaliplatin (mFOLFOX) regimen. Eur J Cancer 2015;3:399
- Turkoglu EB, Dikci S, Çelik E, et al. Thiol/disulfide homeostasis in patients with central serous chorioretinopathy. Curr Eye Res 2016;22:1–3
- Dogru A, Balkarli A, Cetin GY, et al. Thiol/disulfide homeostasis in patients with ankylosing spondylitis. Bosn J Basic Med Sci 2016;16:187–192
- Şimşek E, Erel O, Bicer CK, Çarlıoğlu A. A novel method for determining the relation between nasal polyposis and oxidative stress: the thiol/disulphide homeostasis. Acta Otolaryngol 2016;25:1–4
- Ergin M, Cendek BD, Neselioglu S, et al. Dynamic thiol-disulfide homeostasis in hyperemesis gravidarum. J Perinatol 2015;35:788–792
- Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014;47:326–332
- Demirseren DD, Emre S, Akoğlu G, et al. Evaluation of oxidative stress in patients with non-melanoma skin tumours. MDJ Turk Acad Dermatol 2014;8:1482a2
- Dirican N, Dirican A, Sen O, et al. Thiol/disulfide homeostasis: a prognostic biomarker for patients with advanced non-small cell lung cancer? Redox Rep 2016;21:197–203